194 related articles for article (PubMed ID: 12032622)
1. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease.
Heine RJ; Dekker JM
Diabetologia; 2002 Apr; 45(4):461-75. PubMed ID: 12032622
[TBL] [Abstract][Full Text] [Related]
2. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
3. What does postprandial hyperglycaemia mean?
Heine RJ; Balkau B; Ceriello A; Del Prato S; Horton ES; Taskinen MR
Diabet Med; 2004 Mar; 21(3):208-13. PubMed ID: 15008828
[TBL] [Abstract][Full Text] [Related]
4. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
Monnier L; Colette C
Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
[TBL] [Abstract][Full Text] [Related]
5. Postprandial dysmetabolism and large-vessel disease.
Segal P
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):3-8. PubMed ID: 12702001
[TBL] [Abstract][Full Text] [Related]
6. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.
Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
Diabetologia; 2011 Jan; 54(1):69-72. PubMed ID: 20886203
[TBL] [Abstract][Full Text] [Related]
7. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
Monnier L; Colette C; Owens DR
Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
[TBL] [Abstract][Full Text] [Related]
8. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
9. Glycaemic instability is an underestimated problem in Type II diabetes.
Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
[TBL] [Abstract][Full Text] [Related]
10. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
[TBL] [Abstract][Full Text] [Related]
11. The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.
Su JB; Yang XH; Zhang XL; Cai HL; Huang HY; Zhao LH; Xu F; Chen T; Cheng XB; Wang XQ; Lu Y
PLoS One; 2017; 12(8):e0183055. PubMed ID: 28846720
[TBL] [Abstract][Full Text] [Related]
12. Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.
Peter R; Okoseime OE; Rees A; Owens DR
Curr Vasc Pharmacol; 2009 Jan; 7(1):68-74. PubMed ID: 19149642
[TBL] [Abstract][Full Text] [Related]
13. In search of normoglycaemia in diabetes: controlling postprandial glucose.
Del Prato S
Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S9-17. PubMed ID: 12174318
[TBL] [Abstract][Full Text] [Related]
14. Prandial hyperglycemia: is it important to track and treat?
Hanefeld M; Schaper F
Curr Diab Rep; 2005 Oct; 5(5):333-9. PubMed ID: 16188167
[TBL] [Abstract][Full Text] [Related]
15. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions.
Dworacka M; Winiarska H; Szymanska M; Kuczynski S; Szczawinska K; Wierusz-Wysocka B
Int J Clin Pract Suppl; 2002 Jul; (129):40-4. PubMed ID: 12166605
[TBL] [Abstract][Full Text] [Related]
16. Postprandial glycaemic excursions and cardiovascular risk.
Pradeepa R; Mohan V
J Indian Med Assoc; 2011 Dec; 109(12):912, 917-20. PubMed ID: 23469575
[TBL] [Abstract][Full Text] [Related]
17. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
18. The postprandial state and risk of cardiovascular disease.
Lefèbvre PJ; Scheen AJ
Diabet Med; 1998; 15 Suppl 4():S63-8. PubMed ID: 9868996
[TBL] [Abstract][Full Text] [Related]
19. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
Paul SK; Holman RR
Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
[TBL] [Abstract][Full Text] [Related]
20. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia.
Bellomo Damato A; Stefanelli G; Laviola L; Giorgino R; Giorgino F
Diabet Med; 2011 May; 28(5):560-6. PubMed ID: 21204958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
